Perspective · 26 Nov 2025
PerspectivePublished 26 Nov 2025
HPV Progress: Vaccination, Screening, Treatment, Global.
Department of Oncology, University of California, San Francisco, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
This collection of 2023 research examines HPV vaccination, screening, prevalence, and treatment. Studies reveal challenges in vaccine uptake, knowledge gaps, and confirm vaccine safety and efficacy. Innovations in HPV DNA methylation and Artificial Intelligence (AI) enhance screening. Research also highlights HPV prevalence globally, its burden in HIV-positive women and men, and evolving treatment strategies for HPV-positive cancers. These findings collectively support global cervical cancer elimination efforts through optimized vaccination and screening programs.
Keywords
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Cervical Cancer: Open Access.
Opinion · 26 Nov 2025
Evolving Cervical Cancer Screening: HPV, Tech, Equity
Perspective · 26 Nov 2025
HPV Vaccines: Proven Efficacy, Safety, Global Impact
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCervical Cancer: Open Access
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Emily Robertson”
